Agendia Announces First Patient Enrolled in Prospective LESS Clinical Study, Sponsored by Unicancer, to De-escalate Endocrine Therapy in Women with Early Breast Cancer
The LESS study will evaluate reduced endocrine therapy for HR+/HER2- Read More
The LESS study will evaluate reduced endocrine therapy for HR+/HER2- Read More
Data show MammaPrint® is the first and most comprehensive FDA-cleared test Read More
PUBLICATION: ASCO 2021 Authors Joyce O’Shaughnessy1, Virginia G. Kaklamani2, Read More
Publication: Miami Breast Authors Pat Whitworth, James Read More
Publication: Miami Breast Authors: Pat Whitworth, Jennifer A. Crozier, Robert Read More
Agendia to Participate in the BTIG MedTech, Digital Health, Life Read More
PUBLICATION:SABCS 2020AUTHORS:Laura Lee, Sami Diab, Julie Barone, Jennifer A. Crozier, Read More
PUBLICATION: SABCS 2020 AUTHORS: Pat Whitworth, James V Pellicane, Read More
PUBLICATION: SABCS 2020 AUTHORS:Iris Noordhoek, Esther Bastiaannet, Ersan Lujinovic, Laura Read More
Clinical utility of molecular subtyping and risk of recurrence profiling Read More